$CAH
CARDINAL HEALTH INC Stock $cah

$cah Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000072137124000121 Filed on November 01, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$52.28B
YoY Change		-4.54%
Cost Of Revenue		$50.38B
YoY Change		-4.94%
Gross Profit		$1.902B
YoY Change		7.58%
Gross Profit Margin		3.64%
Selling, General & Admin		$1.277B
YoY Change		6.68%
% of Gross Profit		67.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$182.0M
YoY Change		5.81%
% of Gross Profit		9.57%
Operating Expenses		$1.277B
YoY Change		6.68%
Operating Profit		$568.0M
YoY Change		-4157.14%
Interest Expense		$32.00M
YoY Change		128.57%
% of Operating Profit		5.63%
Other Income/Expense, Net		$5.000M
YoY Change		150.0%
Pretax Income		$541.0M
YoY Change		-2180.77%
Income Tax		$124.0M
% Of Pretax Income		22.92%
Net Earnings		$416.0M
YoY Change		8220.0%
Net Earnings / Revenue		0.8%
Basic Earnings Per Share		$1.71
Diluted Earnings Per Share		$1.70
COMMON SHARES
Basic Shares Outstanding	242.0M shares	243.8M shares
Diluted Shares Outstanding		245.0M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.867B
YoY Change		-25.61%
Cash & Equivalents		$2.867B
Short-Term Investments
Other Short-Term Assets		$2.591B
YoY Change		0.35%
Inventory		$15.62B
Prepaid Expenses
Receivables		$11.78B
Other Receivables		$0.00
Total Short-Term Assets		$32.91B
YoY Change		-5.14%
LONG-TERM ASSETS
Property, Plant & Equipment		$2.535B
YoY Change		3.85%
Goodwill		$4.725B
YoY Change		17.39%
Intangibles		$1.663B
YoY Change		18.19%
Long-Term Investments
YoY Change
Other Assets		$1.231B
YoY Change		7.14%
Total Long-Term Assets		$10.15B
YoY Change		12.55%
TOTAL ASSETS
Total Short-Term Assets		$32.91B
Total Long-Term Assets		$10.15B
Total Assets		$43.06B
YoY Change		-1.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$30.37B
YoY Change		-3.73%
Accrued Expenses		$3.373B
YoY Change		23.24%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$940.0M
YoY Change		19.29%
Total Short-Term Liabilities		$34.68B
YoY Change		-1.1%
LONG-TERM LIABILITIES
Long-Term Debt		$4.224B
YoY Change		8.59%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$4.224B
YoY Change		8.59%
TOTAL LIABILITIES
Total Short-Term Liabilities		$34.68B
Total Long-Term Liabilities		$4.224B
Total Liabilities		$46.34B
YoY Change		-1.83%
SHAREHOLDERS EQUITY
Retained Earnings		$14.00M
YoY Change		-102.14%
Common Stock		$2.827B
YoY Change		3.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$5.963B
YoY Change		10.43%
Treasury Stock Shares
Shareholders Equity		-$3.277B
YoY Change
Total Liabilities & Shareholders Equity		$43.06B
YoY Change		-1.49%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$416.0M
YoY Change		8220.0%
Depreciation, Depletion And Amortization		$182.0M
YoY Change		5.81%
Cash From Operating Activities		-$1.647B
YoY Change		-402.2%
INVESTING ACTIVITIES
Capital Expenditures		$90.00M
YoY Change		-2.17%
Acquisitions
YoY Change
Other Investing Activities		$2.000M
YoY Change		-93.1%
Cash From Investing Activities		-$88.00M
YoY Change		39.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$9.000M
YoY Change		28.57%
Cash From Financing Activities		-$540.0M
YoY Change		-18.92%
NET CHANGE
Cash From Operating Activities		-$1.647B
Cash From Investing Activities		-$88.00M
Cash From Financing Activities		-$540.0M
Net Change In Cash		-$2.266B
YoY Change		1098.94%
FREE CASH FLOW
Cash From Operating Activities		-$1.647B
Capital Expenditures		$90.00M
Free Cash Flow		-$1.737B
YoY Change		-483.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000721371
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	Cardinal Health, Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-0958666
CY2024Q3	dei	Trading Symbol TradingSymbol	CAH
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	us-gaap	Revenues Revenues	54650000000	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	242010503	shares
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	us-gaap	Revenues Revenues	52277000000	usd
CY2023Q3	us-gaap	Revenues Revenues	54650000000	usd
CY2023Q3	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#GainLossOnSalesOfAssetsAndAssetImpairmentCharges
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	7000 Cardinal Place
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43017
CY2024Q3	dei	City Area Code CityAreaCode	614
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	757-5000
CY2024Q3	dei	Security12b Title Security12bTitle	Common shares (without par value)
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	50375000000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	52907000000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1902000000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1743000000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1277000000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1186000000	usd
CY2024Q3	us-gaap	Restructuring Charges RestructuringCharges	24000000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	25000000	usd
CY2024Q3	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	74000000	usd
CY2023Q3	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	64000000	usd
CY2024Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	1000000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-541000000	usd
CY2024Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	40000000	usd
CY2023Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	41000000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	568000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-32000000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	32000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	11000000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	541000000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44000000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124000000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-33000000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	417000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-11000000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	416000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-12000000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.71
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	249000000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	245000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	249000000	shares
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5056
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5006
CY2024Q3	us-gaap	Profit Loss ProfitLoss	417000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-11000000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-11000000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-3000000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14000000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	429000000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-25000000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	428000000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26000000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2867000000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5133000000	usd
CY2024Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	11781000000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	12084000000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	15619000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	14957000000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2591000000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2663000000	usd
CY2024Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	47000000	usd
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	47000000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	32905000000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	34884000000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2535000000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2529000000	usd
CY2024Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	6388000000	usd
CY2024Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	6450000000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1231000000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1258000000	usd
CY2024Q3	us-gaap	Assets Assets	43059000000	usd
CY2024Q2	us-gaap	Assets Assets	45121000000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	30365000000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	31759000000	usd
CY2024Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	940000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	434000000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3373000000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3447000000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	34678000000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	35640000000	usd
CY2024Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4224000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4658000000	usd
CY2024Q3	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	7433000000	usd
CY2024Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	8035000000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	2827000000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	2917000000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-286000000	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	85000000	shares
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	83000000	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	5963000000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	5677000000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-155000000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-167000000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-3277000000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3213000000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	1000000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	1000000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3276000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3212000000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43059000000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45121000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3212000000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	416000000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	417000000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12000000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2000000	usd
CY2024Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	378000000	usd
CY2024Q3	us-gaap	Dividends Dividends	119000000	usd
CY2024Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	2000000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3276000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2957000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-12000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-11000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7000000	usd
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	505000000	usd
CY2023Q3	us-gaap	Dividends Dividends	125000000	usd
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	-2000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3607000000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	417000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-11000000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	182000000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	172000000	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1000000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2024Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	1000000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-541000000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	30000000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	29000000	usd
CY2024Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	16000000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9000000	usd
CY2024Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-288000000	usd
CY2023Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-58000000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	678000000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1073000000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1394000000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1762000000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	508000000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	959000000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1647000000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	528000000	usd
CY2024Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	2000000	usd
CY2023Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	90000000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92000000	usd
CY2024Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000000	usd
CY2024Q3	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	0	usd
CY2023Q3	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	28000000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-88000000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63000000	usd
CY2024Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9000000	usd
CY2023Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000000	usd
CY2024Q3	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-28000000	usd
CY2023Q3	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-28000000	usd
CY2024Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	128000000	usd
CY2023Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	131000000	usd
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	375000000	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-540000000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-666000000	usd
CY2024Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9000000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2266000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-206000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5133000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4076000000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2867000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3870000000	usd
CY2024Q3	us-gaap	Severance Costs1 SeveranceCosts1	16000000	usd
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1	7000000	usd
CY2024Q3	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	8000000	usd
CY2023Q3	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	18000000	usd
CY2024Q3	us-gaap	Restructuring Charges RestructuringCharges	24000000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	25000000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	97000000	usd
CY2024Q3	us-gaap	Restructuring Costs RestructuringCosts	7000000	usd
CY2024Q3	us-gaap	Payments For Restructuring PaymentsForRestructuring	10000000	usd
CY2024Q3	us-gaap	Restructuring Reserve RestructuringReserve	94000000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	4725000000	usd
CY2024Q3	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2024Q3	us-gaap	Goodwill Goodwill	4725000000	usd
CY2024Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	usd
CY2024Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5260000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3609000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1651000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
CY2024Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5272000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3609000000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1663000000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5236000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3523000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1713000000	usd
CY2024Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5248000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3523000000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1725000000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	68000000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	200000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	246000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	219000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	191000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	186000000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	5200000000	usd
CY2024Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	5100000000	usd
CY2024Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	30400000000	usd
CY2024Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	31800000000	usd
CY2024Q3	cah	Incomefrom Settlementsof Class Action Lawsuits IncomefromSettlementsofClassActionLawsuits	43000000	usd
CY2023Q3	cah	Incomefrom Settlementsof Class Action Lawsuits IncomefromSettlementsofClassActionLawsuits	41000000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.751
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	952000000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	981000000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	871000000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	882000000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	69000000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	65000000	usd
CY2024Q3	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	0	usd
CY2024Q3	cah	Carrying Amountof Long Termandother Short Term Borrowings CarryingAmountofLongTermandotherShortTermBorrowings	5164000000	usd
CY2024Q2	cah	Carrying Amountof Long Termandother Short Term Borrowings CarryingAmountofLongTermandotherShortTermBorrowings	5092000000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	5000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3000000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	249000000	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	245000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	249000000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2023Q3	cah	Antidilutive Securities Excluded From Computation Of Eps As A Result Of The Net Loss During The Period AntidilutiveSecuritiesExcludedFromComputationOfEPSAsAResultOfTheNetLossDuringThePeriod	1000000	shares
CY2024Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	us-gaap	Revenues Revenues	52277000000	usd
CY2023Q3	us-gaap	Revenues Revenues	54650000000	usd
CY2024Q3	us-gaap	Revenues Revenues	52277000000	usd
CY2024Q3	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	12000000	usd
CY2023Q3	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	6000000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	568000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-32000000	usd
CY2024Q3	us-gaap	Assets Assets	43059000000	usd
CY2024Q2	us-gaap	Assets Assets	45121000000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30000000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4000000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4000000	usd

Files In Submission

Name	View Source	Status
0000721371-24-000121-index-headers.html	Edgar Link	pending
0000721371-24-000121-index.html	Edgar Link	pending
0000721371-24-000121.txt	Edgar Link	pending
0000721371-24-000121-xbrl.zip	Edgar Link	pending
a25q1_10qx093024xexhibit311.htm	Edgar Link	pending
a25q1_10qx093024xexhibit312.htm	Edgar Link	pending
a25q1_10qx093024xexhibit321.htm	Edgar Link	pending
a25q1_10qx093024xexhibit991.htm	Edgar Link	pending
cah-20240930.htm	Edgar Link	pending
cah-20240930.xsd	Edgar Link	pending
cah-20240930_g1.jpg	Edgar Link	pending
cah-20240930_g2.jpg	Edgar Link	pending
cah-20240930_g3.jpg	Edgar Link	pending
cah-20240930_g4.jpg	Edgar Link	pending
cah-20240930_g5.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
cah-20240930_def.xml	Edgar Link	unprocessable
cah-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cah-20240930_lab.xml	Edgar Link	unprocessable
cah-20240930_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cah-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAH
CARDINAL HEALTH INC Stock $cah

2024 Q4 Form 10-Q Financial Statement

#000072137124000121 Filed on November 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH CARDINAL HEALTH INC Stock $cah

2024 Q4 Form 10-Q Financial Statement

#000072137124000121 Filed on November 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH
CARDINAL HEALTH INC Stock $cah